|
|
Blood, 15 March 2005, Vol. 105, No. 6, pp. 2332-2339.
Prepublished online as a Blood First Edition Paper on November 18, 2004; DOI 10.1182/blood-2004-09-3659.
Previous Article | Next Article 
Submitted September 22, 2004
Accepted November 3, 2004
Functional characterization of telomerase RNA variants found in patients with hematological disorders
Hinh Ly*, Rodrigo T Calado, Paulette Allard, Gabriela M Baerlocher, Peter M Lansdorp, Neal S Young, and Tristram G Parslow
Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA
Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, MD, USA
Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada
* Corresponding author; email: hly{at}emory.edu.
Human telomerase uses a specific cellular RNA, called hTERC, as the template to synthesize telomere repeats at chromosome ends. Approximately 10-15% of patients with aplastic anemia or other bone marrow failure syndromes are carriers of hTERC sequence polymorphisms whose functional significance, in most cases, is unknown. We screened ten reported and two newly discovered hTERC variants from such patients and found that ten of these negatively affected telomerase enzymatic function when they were used to reconstitute telomerase enzymatic function in human cells. Most functional deficits were due to perturbations of hTERC secondary structure and correlated well with the degrees of telomere shortening and reduced telomerase activity observed in peripheral blood lymphocytes of the representative patients. We also found no evidence of dominant negative activity in any of the mutants. Therefore, loss of telomerase activity and of telomere maintenance resulting from inherited hTERC mutations may limit marrow stem-cell renewal and predispose some patients to bone marrow failure.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. T. Calado and N. S. Young
Telomere maintenance and human bone marrow failure
Blood,
May 1, 2008;
111(9):
4446 - 4455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. D. Goldman, G. Aubert, A. J. Klingelhutz, M. Hills, S. R. Cooper, W. S. Hamilton, A. J. Schlueter, K. Lambie, C. J. Eaves, and P. M. Lansdorp
Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita
Blood,
May 1, 2008;
111(9):
4523 - 4531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Xie, A. Mosig, X. Qi, Y. Li, P. F. Stadler, and J. J.-L. Chen
Structure and Function of the Smallest Vertebrate Telomerase RNA from Teleost Fish
J. Biol. Chem.,
January 25, 2008;
283(4):
2049 - 2059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Marrone, A. Walne, H. Tamary, Y. Masunari, M. Kirwan, R. Beswick, T. Vulliamy, and I. Dokal
Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome
Blood,
December 15, 2007;
110(13):
4198 - 4205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Garcia, W. E. Wright, and J. W. Shay
Human diseases of telomerase dysfunction: insights into tissue aging
Nucleic Acids Res.,
December 3, 2007;
35(22):
7406 - 7416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Marrone, P. Sokhal, A. Walne, R. Beswick, M. Kirwan, S. Killick, M. Williams, J. Marsh, T. Vulliamy, and I. Dokal
Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations
Haematologica,
August 1, 2007;
92(8):
1013 - 1020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Li, H. Nishizuka, K. Tsutsumi, Y. Imai, Y. Kurihara, and S. Uesugi
Structure, Interactions and Effects on Activity of the 5'-terminal Region of Human telomerase RNA
J. Biochem.,
May 1, 2007;
141(5):
755 - 765.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-T. Xin, A. D. Beauchamp, R. T. Calado, J. W. Bradford, J. A. Regal, A. Shenoy, Y. Liang, P. M. Lansdorp, N. S. Young, and H. Ly
Functional characterization of natural telomerase mutations found in patients with hematologic disorders
Blood,
January 15, 2007;
109(2):
524 - 532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Vulliamy, A. Marrone, S. W. Knight, A. Walne, P. J. Mason, and I. Dokal
Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation
Blood,
April 1, 2006;
107(7):
2680 - 2685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ly, M. Schertzer, W. Jastaniah, J. Davis, S. L. Yong, Q. Ouyang, E. H. Blackburn, T. G. Parslow, and P. M. Lansdorp
Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita
Blood,
August 15, 2005;
106(4):
1246 - 1252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yamaguchi, R. T. Calado, H. Ly, S. Kajigaya, G. M. Baerlocher, S. J. Chanock, P. M. Lansdorp, and N. S. Young
Mutations in TERT, the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia
N. Engl. J. Med.,
April 7, 2005;
352(14):
1413 - 1424.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |